Fibrobiologics Inc (FBLG)

Jun 14, 2026

FBLG Q1 2026 Earnings: Slight EPS Miss as Pre-Revenue Biotech Advances PipelineHigh Estimate Range - newsline.com

Jun 14, 2026

Jun 13, 2026

FibroBiologics (FBLG) Declines Amid Volatility, Nears Critical Support ZoneValue Area Low - newsline.com

Jun 13, 2026

Jun 11, 2026

FibroBiologics Inc. (FBLG) Slides 3% as Selling Pressure Tests Key Support ZoneEnding Diagonal - newsline.com

Jun 11, 2026

Jun 10, 2026

FIBROBIOLOGICS INC (FBLG) Stock Chart - ChartMill

Jun 10, 2026

Jun 08, 2026

FibroBiologics Inc. (FBLG) Q1 2026 Earnings: Narrow EPS Miss Highlights Pre-Revenue Biotech Challenges - newsline.com

Jun 08, 2026

Jun 04, 2026

FBLG: Phase 1/2 Trial of CYWC628 Underway - Zacks Small Cap Research

Jun 04, 2026

Jun 04, 2026

EXCLUSIVE: FibroBiologics Doses First Patients In Diabetic Foot Ulcers Clinical Trial - Sahm

Jun 04, 2026

Jun 04, 2026

FibroBiologics begins dosing patients in diabetic ulcer trial By Investing.com - Investing.com South Africa

Jun 04, 2026

Jun 04, 2026

FibroBiologics begins dosing patients in diabetic ulcer trial - Investing.com UK

Jun 04, 2026

Jun 03, 2026

FibroBiologics (FBLG) Begins Clinical Trial for Diabetic Foot Ulcers Treatment - GuruFocus

Jun 03, 2026

Jun 03, 2026

Fibrobiologics Announces First Patients Dosed In Phase 1/2 Clinical Trial Evaluating Cywc628 For The Treatment Of Diabetic Foot Ulcers - TradingView

Jun 03, 2026

Jun 03, 2026

FibroBiologics Announces First Patients Dosed in Phase 1/2 Clinical Trial Evaluating CYWC628 for the Treatment of Diabetic Foot Ulcers - The Manila Times

Jun 03, 2026

Jun 03, 2026

Experimental cell therapy for diabetic foot ulcers starts dosing patients - Stock Titan

Jun 03, 2026

Jun 02, 2026

Is FibroBiologics, Inc. (FBLG) Advancing Toward a Breakthrough Psoriasis Treatment With CYPS317 Data? - Insider Monkey

Jun 02, 2026

May 31, 2026

10 Popular Penny Stocks on Robinhood to Watch in 2026 - Insider Monkey

May 31, 2026

May 29, 2026

FBLG Stock Price, Quote & Chart | FIBROBIOLOGICS INC (NASDAQ:FBLG) - ChartMill

May 29, 2026

May 23, 2026

FibroBiologics Presents Preclinical Data Demonstrating Durable Immunomodulation in Psoriasis at the Society for Investigative Dermatology 2026 Annual Meeting - Sahm

May 23, 2026

May 22, 2026

D. Boral Capital Maintains FibroBiologics (FBLG) Buy Recommendation - MSN

May 22, 2026

May 22, 2026

symbol__ Stock Quote Price and Forecast - CNN

May 22, 2026

May 19, 2026

Exclusive: FibroBiologics moves forward with human trial for diabetic foot ulcer therapy - MSN

May 19, 2026

May 18, 2026

FibroBiologics files patent for oral fibroblast delivery system - Investing.com UK

May 18, 2026

May 18, 2026

FibroBiologics files patent for oral fibroblast delivery system By Investing.com - Investing.com Australia

May 18, 2026

May 18, 2026

FibroBiologics Files Patent Application for Oral Administration of Fibroblast Therapeutics - GlobeNewswire

May 18, 2026

May 16, 2026

Exclusive: FibroBiologics targets 2026 data readout after trial progress for diabetic foot ulcer study - MSN

May 16, 2026

May 12, 2026

TradingKey - TradingKey

May 12, 2026

May 12, 2026

Fibrobiologics explores use of fibroblast platform for hantavirus - BioWorld News

May 12, 2026

May 11, 2026

FibroBiologics Advancing Development of a Fibroblast Treatment for Hantavirus - GlobeNewswire

May 11, 2026

May 11, 2026

Severe Hantavirus syndrome lacks drugs, FibroBiologics tests fibroblast therapy - Stock Titan

May 11, 2026

May 07, 2026

FibroBiologics, Inc. Files Form 8-K Announcing Material Definitive Agreement and Company Details - Minichart

May 07, 2026

May 07, 2026

FibroBiologics | 424B5: Prospectus - Moomoo

May 07, 2026

May 07, 2026

FBLG | FibroBiologics, Inc. Common Stock Executive Compensation - Quiver Quantitative

May 07, 2026

May 06, 2026

FibroBiologics Expands At-The-Market Equity Offering Capacity - TipRanks

May 06, 2026

May 06, 2026

FibroBiologics Grants Stock Options to Key Executives - The Globe and Mail

May 06, 2026

May 06, 2026

FibroBiologics (NASDAQ: FBLG) expands $7.5M at-the-market stock offering - Stock Titan

May 06, 2026